|MiMedx To Webcast Its Investor's Day Conference on November 30, 2017|
The Company reported that "Pete" Petit, Chairman and CEO;
The Investor's Day presentations will provide a comprehensive overview and update on the numerous strategic and tactical initiatives undertaken by the Company, as well as dialog on related details during the planned panel discussions and question and answer session. The panel discussions and presentations will address details related to:
Parker H. "Pete" Petit, Chairman and CEO stated, "We have made rapid progress in advancing our biopharma strategy, growing our compendium of scientific and clinical results, developing expanded market opportunities for our current and future product offerings, and enlarging the Company's substantial asset base to drive our planned growth. We look forward to sharing this information with investors later this month."
In-person attendance at the presentations will be by invitation only. The webcast will be a listen-only simulcast of the presentations beginning at
MiMedx® is the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. "Innovations in Regenerative Medicine" is the framework behind our mission to give physicians products and tissues to help the body heal itself. We process the human placental tissue utilizing our proprietary PURION® Process among other processes, to produce safe and effective allografts. MiMedx proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization.
Important Cautionary Statement
This press release includes forward-looking statements including that the Company's biopharmaceutical strategy, compendium of scientific and clinical results, current and future product offerings, and asset base will drive growth. These statements also may be identified by words such as "believe," "except," "may," "plan," "potential," "will" and similar expressions, and are based on our current beliefs and expectations. Forward-looking statements are subject to significant risks and uncertainties, and we caution investors against placing undue reliance on such statements. Actual results may differ materially from those set forth in the forward-looking statements. Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include that the Company's growth may not materialize as planned. For more detailed information on the risks and uncertainties, please review the Risk Factors section of our most recent annual report or quarterly report filed with the
Investor Contact: COCKRELL GROUP, Rich Cockrell, 877-889-1972, firstname.lastname@example.org, cockrellgroup.com; Press Contact: Michael Senken, Phone: (770) 651-9100